knowledge -WSS

knowledge

author：entertainment 2025-10-02 20:47:24 - browse：33729

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Bernie Sanders is gearing up to subpoena pharma CEOs

explore

WSS

Humana’s losses in Medicare Advantage tank its stock

New rules on organ donation and transplantation 'will bring chaos'

Humana’s losses in Medicare Advantage tank its stock

Body of missing toddler recovered in Delaware River days after flood: Police

Court strikes down limits on filming of police in Arizona

The Affordable Care Act has saved billions in health care costs

entertainment

knowledge

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Merck, Johnson & Johnson CEOs will testify on high drug prices

After affirmative action ruling, medical educators look to 'holistic review'

White House pharmacy plagued with problems, investigation finds

New air purifier tech could be key to improving indoor air quality

White House pharmacy plagued with problems, investigation finds

Activists slam private health insurers over coverage restrictions

Court strikes down limits on filming of police in Arizona

In Memoriam: Notable people who died in 2023

Investment in vaccine development is lagging, report finds

focus

Zyn nicotine pouches become unlikely player in latest culture war

Readout Newsletter: The latest on Novavax, Merck, Bluebird

HIPAA doesn't protect reproductive records from prosecutors

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

How artificial intelligence is being used to detect, treat cancer

CDC backtracks, saying fully vaccinated people can go maskless indoors

explore

hotspot

entertainment

focus